SpringWorks Therapeutics ... (SWTX)
49.39
-1.49 (-2.93%)
At close: Mar 13, 2025, 11:48 AM
SpringWorks Therapeutics Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -258.13M | -325.1M | -277.42M | -173.91M | -45.57M | -58.31M | -17.81M | -4.64M |
| Depreciation & Amortization | 3.47M | 1.67M | 765K | 490K | 349K | 192K | 17K | 3.18K |
| Stock-Based Compensation | 109.14M | 94.53M | 72.97M | 38.44M | 10.03M | 3.11M | 1.07M | n/a |
| Other Working Capital | 4.95M | 8.65M | 33.94M | 3.04M | 2.65M | 3.07M | 1.53M | 100K |
| Other Non-Cash Items | 7.79M | 6.69M | 4.02M | 993K | 1.05M | 2.61M | 612.33K | 1.74M |
| Deferred Income Tax | n/a | n/a | n/a | 988K | 605K | n/a | n/a | n/a |
| Change in Working Capital | -37.86M | -583K | 38.1M | 5.12M | 1.35M | 4.95M | 2.02M | 383K |
| Operating Cash Flow | -175.6M | -222.79M | -161.56M | -127.88M | -32.19M | -47.44M | -14.71M | -2.24M |
| Capital Expenditures | -4.45M | -7.38M | -10.2M | -2.02M | -642K | -670K | -293K | -44K |
| Acquisitions | n/a | -2.8M | -4.2M | 2.02M | -3.5M | -3.59M | n/a | n/a |
| Purchase of Investments | -285.1M | -575.72M | -481.05M | -305.42M | -442.69M | -3.59M | n/a | n/a |
| Sales Maturities Of Investments | 378.58M | 620.66M | 279.85M | 391.03M | 28M | 3.59M | n/a | n/a |
| Other Investing Acitivies | -24.48M | n/a | -205.4M | -2.02M | -418.19M | -3.59K | n/a | n/a |
| Investing Cash Flow | 64.55M | 34.75M | -215.6M | 83.59M | -418.83M | -4.26M | -293K | -44K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | -8.44M | -2.8M | -1.34M | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 4.76M | 278K | 1.98M | 1.16M | 893K | 163.98M | 50.38M | 12.55M |
| Financial Cash Flow | 4.76M | 296.64M | 340.7M | 1.16M | 270.49M | 333.71M | 50.38M | 12.55M |
| Net Cash Flow | -106.29M | 108.6M | -36.46M | -43.13M | -180.54M | 282M | 35.38M | 10.27M |
| Free Cash Flow | -180.05M | -230.18M | -171.76M | -129.89M | -32.83M | -48.11M | -15M | -2.28M |